These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21976474)

  • 1. Pharmacokinetics of intravenous teicoplanin in peritoneal dialysis patients with respiratory infections.
    Qi H; Ma X; Zhang P; Gao L; Cui H; Hou F; Wang T
    Perit Dial Int; 2011; 31(5):595-7. PubMed ID: 21976474
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis.
    Stamatiadis D; Papaioannou MG; Giamarellos-Bourboulis EJ; Marinaki S; Giamarellou H; Stathakis CP
    Perit Dial Int; 2003; 23(2):127-31. PubMed ID: 12713078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic behavior of intraperitoneal teicoplanin during treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
    Finch RC; Holliday AP; Innes A; Burden RP; Morgan AG; Shaw PN; Harding I; Wale MC
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1971-2. PubMed ID: 8843320
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment.
    Bonati M; Traina GL; Rosina R; Buniva G
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of teicoplanin in patients undergoing chronic haemodialysis.
    Papaioannou MG; Marinaki S; Pappas M; Stamatiadis D; Giamarellos-Bourboulis EJ; Giamarellou H; Stathakis C
    Int J Antimicrob Agents; 2002 Mar; 19(3):233-6. PubMed ID: 11932147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis.
    Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G; Bonati M
    Eur J Clin Pharmacol; 1986; 31(4):501-4. PubMed ID: 2949981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of teicoplanin and vancomycin.
    Harding I; Sorgel F
    J Chemother; 2000 Nov; 12 Suppl 5():15-20. PubMed ID: 11131959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teicoplanin pharmacokinetics and bioavailability during peritoneal dialysis.
    Brouard RJ; Kapusnik JE; Gambertoglio JG; Schoenfeld PY; Sachdeva M; Freel K; Tozer TN
    Clin Pharmacol Ther; 1989 Jun; 45(6):674-81. PubMed ID: 2525081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial Lining Fluid and Plasma Concentrations of Dalbavancin in Healthy Adults after a Single 1,500-Milligram Infusion.
    Rappo U; Dunne MW; Puttagunta S; Baldassarre JS; Su S; Desai-Krieger D; Inoue M
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31501147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.
    Thalhammer F; Rosenkranz AR; Burgmann H; Graninger W; Hollenstein U; Schenk P; Thalhammer-Scherrer R; Traindl O; Hörl WH; Breyer S
    Wien Klin Wochenschr; 1997 May; 109(10):362-5. PubMed ID: 9200809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
    Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian approach to drug disposition evaluation: application to teicoplanin.
    Ferrante L; Bompadre S; Cingolani ML; Leone L
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):410-4. PubMed ID: 7582399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Benziger DP; Pertel PE; Donovan J; Yankelev S; Schwab RJ; Swan SK; Cannon C
    Clin Nephrol; 2011 Jan; 75(1):63-9. PubMed ID: 21176752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of arterio-venous haemofiltration on teicoplanin elimination.
    Hillaire-Buys D; Peyriere H; Lobjoie E; Bres J; Ossart M; Despaux E
    Br J Clin Pharmacol; 1995 Jul; 40(1):95-7. PubMed ID: 8527277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal loading regimen and achievement of trough concentrations for teicoplanin using Japanese population parameters.
    Hiraki Y; Yasumori N; Nagano M; Inoue D; Tsuji Y; Kamimura H; Karube Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):87-8. PubMed ID: 25459402
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of arteriovenous hemofiltration on teicoplanin pharmacokinetics].
    Choufane S; Lobjoie E; Tinturier F
    Ann Fr Anesth Reanim; 1996; 15(8):1168-72. PubMed ID: 9636789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen.
    Cazaubon Y; Venisse N; Mimoz O; Maire P; Ducher M; Bourguignon L; Goutelle S
    J Antimicrob Chemother; 2017 Oct; 72(10):2804-2812. PubMed ID: 29091222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal teicoplanin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis.
    Bowley JA; Pickering SJ; Scantlebury AJ; Ackrill P; Jones DM
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():133-9. PubMed ID: 2965125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced loading regimen of teicoplanin is necessary to achieve therapeutic pharmacokinetics levels for the improvement of clinical outcomes in patients with renal dysfunction.
    Ueda T; Takesue Y; Nakajima K; Ichiki K; Doita A; Wada Y; Tsuchida T; Takahashi Y; Ishihara M; Ikeuchi H; Uchino M; Kimura T
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1501-9. PubMed ID: 27278654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intraventricularly administered teicoplanin in Staphylococci ventriculitis.
    Beenen LF; Touw DJ; Hekker TA; Haring DA
    Pharm World Sci; 2000 Aug; 22(4):127-9. PubMed ID: 11103381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.